09:01:07 EDT Sun 20 Apr 2025
Enter Symbol
or Name
USA
CA



C:PREV - PreveCeutical Medical Inc. - https://www.preveceutical.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PREV - C  116.00.03·0.035701.20.03    0.045  0.015Apr 17Apr 1515 min RT 2¢
CSE - C116.00.03·0.035701.20.03    0.045  0.015Apr 1715 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-04-15 04:12C:PREV0.03News ReleasePreveceutical further increases placement to $700,000
2025-04-02 19:47C:PREV0.025News ReleasePreveceutical increases private placement to $500,000
2025-03-10 19:21C:PREV0.02News ReleasePreveceutical Medical extends private placement
2025-02-06 16:06C:PREV0.03News ReleasePreveceutical to develop N2B Sol-Gel program
2025-02-04 17:33C:PREV0.025News ReleasePreveceutical appoints Jones to lead Sol-Gel projects
2025-01-24 17:42C:PREV0.025News ReleasePreveceutical Medical arranges $300,000 unit financing
2025-01-07 12:55C:PREV0.025News ReleaseBioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
2024-12-18 19:05C:PREV0.02News ReleasePreveceutical changes auditor to Davidson & Company
2024-12-09 16:14C:PREV0.025News ReleasePreveceutical's BioGene appoints Lawson as director
2024-12-05 16:26C:PREV0.025News ReleasePreveceutical's BioGene adds Ticho to advisory board
2024-12-04 16:19C:PREV0.025News ReleasePreveceutical's BioGene appoints advisory board member
2024-12-02 17:23C:PREV0.02News ReleasePreveceutical unit appoints Glover independent director
2024-11-27 14:40C:PREV0.02SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-27 14:39C:PREV0.02SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-25 16:07C:PREV0.02News ReleasePreveceutical's BioGene appoints Sampath as director
2024-11-21 16:43C:PREV0.02News ReleasePreveceutical's BioGene adds Dellbegovic as adviser
2024-11-18 14:50C:PREV0.02News ReleasePreveceutical's BioGene appoints Olofsson as CSO
2024-11-15 15:13C:PREV0.02News ReleasePreveceutical Medical closes IP asset sale to BioGene
2024-11-13 12:22C:PREV0.02News ReleasePreveceutical appoints Georgieva as BioGene president
2024-10-30 13:17C:PREVNews ReleasePreveceutical to sell IP to BioGene for $1.35M (U.S.)